DRAM vs SMH: Which Is the Better Pick in 2026?

Overview

DRAM and SMH are both semiconductor-focused technology ETFs, but they differ fundamentally in scope and philosophy. DRAM targets memory-chip companies specifically—a thematic, growth-oriented strategy that captures AI-driven demand for advanced DRAM and NAND. SMH tracks a broad 25-stock semiconductor index, giving investors diversified exposure across the entire chip ecosystem: processors, memory, analog chips, and equipment makers. The key distinction is concentration: DRAM bets on a single subsector; SMH spreads risk across the semiconductor supply chain.

How they differ

The biggest difference is portfolio construction. DRAM is a thematic play on memory semiconductors, likely holding a narrow set of DRAM and NAND manufacturers; SMH holds 25 publicly listed semiconductor companies tracked by its underlying MVIS US Listed Semiconductor 25 Index. This means DRAM has meaningful concentration risk within memory, while SMH captures lithography, processors, analog, and foundry exposure alongside memory.

Second, SMH has been around since late 2011 and operates at a much larger scale ($69.8B in AUM versus DRAM's $23.4B), with a lower expense ratio of 0.35% compared to DRAM's 0.65%. SMH also pays a modest 0.20% distribution annually; DRAM does not distribute.

Third, their risk profiles differ markedly. SMH's beta of 1.98 indicates it amplifies broad semiconductor sector swings; DRAM's beta of 0.0 suggests either very recent inception data or a structure that does not track a traditional market benchmark. DRAM's April 2026 inception date is notable—this is a very young fund, so performance history is effectively nonexistent.

Who each is best for

• DRAM: Investors convinced that memory-chip demand (especially from AI infrastructure buildout) will outpace the broader semiconductor sector, and who are comfortable concentrating a portion of their tech exposure in a single subsector. Fits thematic, opportunistic allocators with a multi-year conviction thesis on DRAM/NAND specifically.

• SMH: Investors seeking diversified semiconductor exposure without sector bets, who prefer a long-established index-tracking approach and want to avoid concentration in any single chip type. Fits core semiconductor allocators who want to own the entire industry rather than picking subsectors.

Key risks to know

• Concentration in a single subsector. DRAM's thematic focus on memory means its performance hinges on DRAM and NAND cycle strength relative to logic, analog, and foundry chips. If memory demand softens while processors or equipment remain robust, DRAM will lag.

• Extreme youth and limited history. DRAM's inception in April 2026 means there is no real-world performance record, no full market cycle data, and no evidence of how the fund behaves during stress. Investors are essentially backing a recent launch with an untested manager strategy.

• Semiconductor cyclicality and capital intensity. Both funds own companies with volatile earnings tied to chip-cycle demand and requiring massive capex. Downturns can compress valuations quickly; neither fund offers downside protection.

• SMH's elevated beta exposure. A beta of 1.98 means SMH amplifies semiconductor sector volatility—a 20% sector decline would likely translate to a 40% swing in SMH, all else equal. This is suitable for investors with higher risk tolerance and longer time horizons.

• Valuation and AI dependency. Both funds benefit from AI infrastructure demand, which is partially priced into semiconductor stocks. A sustained slowdown in AI capex or a pullback in AI valuations could pressure both funds, though DRAM would face the risk most acutely if memory demand slows.

Bottom line

SMH offers broad semiconductor diversification with 15+ years of performance history, low fees, and an index-tracking mandate—a straightforward way to own the chip sector. DRAM bets you can outperform by concentrating on memory subsectors, but it's brand-new with no track record and higher fees, so the conviction needs to be strong. If you want established, diversified semiconductor exposure, SMH's longer history and lower cost stand out; if you're betting specifically on memory-chip growth, DRAM's thematic focus addresses that thesis—though past performance doesn't predict future results, especially for a fund launched so recently.